Functionality of natural killer cells from end-stage cancer patients exposed to coherent electromagnetic fields

被引:10
|
作者
Evangelou, Angelos
Toliopoulos, Ioannis [2 ]
Giotis, Christos [3 ]
Metsios, Apostolos
Verginadis, Ioannis
Simos, Yannis
Havelas, Konstantinos
Hadziaivazis, Georgios
Karkabounas, Spyridon [1 ]
机构
[1] Univ Ioannina, Fac Med, Dept Physiol, Physiol Lab, GR-45110 Ioannina, Greece
[2] Konstantinion Res Ctr Mol Med & Biotechnol, Thessaloniki, Greece
[3] Gen Hosp Arta, Nephrol Clin, Arta, Greece
关键词
Natural killer cells; Flow cytometry; Coherent electromagnetic fields; Electromagnetic; resonance; MAGNETIC-FIELDS; FLOW-CYTOMETRY; TUMOR-GROWTH; WISTAR RATS; TOXICITY; CHEMOTHERAPY; ENHANCEMENT; LYMPHOCYTES; INHIBITION; SAFETY;
D O I
10.3109/15368378.2011.566776
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The main objective of our study is to investigate whether an enhancement of the immune system in end-stage cancer patients is achieved by exposure to coherent electromagnetic fields. For this reason, 15 end-stage cancer patients were exposed at low intensity, coherent electromagnetic fields at radiofrequencies ranging from 600 kHz--729 Hz, for 8 h/day, 6 days/week for 4 weeks. NKs number and cytotoxicity of NK T-lymphocytes versus K562 cancer cell line were estimated by flow cytometry, before and after exposure. Data showed that the exposure of the end-stage cancer patients to the coherent electromagnetic fields resulted in a significant increase of the number and the cytotoxicity of the NK T-lymphocytes against cancer cells, in all patients. Exposure to coherent EMFs at radiofrequencies increases the number and cytotoxicity of NK T-lymphocytes, which may contribute to the improvement of cancer patients' status.</.
引用
收藏
页码:46 / 56
页数:11
相关论文
共 50 条
  • [1] Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis
    Nagai, Kei
    RENAL REPLACEMENT THERAPY, 2021, 7 (01)
  • [2] Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis
    Kei Nagai
    Renal Replacement Therapy, 7
  • [3] Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity
    Maretti-Mira, Ana C.
    Salomon, Matthew P.
    Hsu, Angela M.
    Dara, Lily
    Golden-Mason, Lucy
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [4] Tim-3 Expression by Peripheral Natural Killer Cells and Natural Killer T Cells Increases in Patients with Lung Cancer - Reduction after Surgical Resection
    Xu, Li-Yun
    Chen, Dong-Dong
    He, Jian-Ying
    Lu, Chang-Chang
    Liu, Xiao-Guang
    Le, Han-Bo
    Wang, Chao-Ye
    Zhang, Yong-Kui
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (22) : 9945 - 9948
  • [5] Stimulation of natural killer cells by homoeopathic complexes: An in vitro and in vivo pilot study in advanced cancer patients
    Toliopoulos, Ioannis K.
    Simos, Yannis
    Bougiouklis, Dimitrios
    Oikonomidis, Stergios
    CELL BIOCHEMISTRY AND FUNCTION, 2013, 31 (08) : 713 - 718
  • [6] Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA)
    Reitsam, Nic G.
    Maerkl, Bruno
    Dintner, Sebastian
    Sipos, Eva
    Grochowski, Przemyslaw
    Grosser, Bianca
    Sommer, Florian
    Eser, Stefan
    Nerlinger, Pia
    Jordan, Frank
    Rank, Andreas
    Loehr, Phillip
    Waidhauser, Johanna
    CANCERS, 2023, 15 (03)
  • [7] Natural killer cell activity unaffected by ozonated autohemotherapy in patients with end-stage renal disease on maintenance renal replacement therapy
    Biedunkiewicz, B
    Tylick, L
    Rachon, D
    Hak, L
    Nieweglowski, T
    Chamienia, A
    Debska-Slizien, A
    Mysliwska, J
    Rutkowski, B
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2004, 27 (09) : 766 - 771
  • [8] The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study
    Li, Zhenyu
    Zhou, Xiaoshu
    Wang, Shuai
    Shi, Liangliang
    Meng, Rui
    Dai, Xiaofang
    Liu, Yi
    Lin, Xueke
    Xiao, Yong
    Peng, Gang
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (04) : 904 - +
  • [9] Histodynamics of Natural Killer Cells from a Healthy Donor Exposed to Exosomes from the Blood of Hepatocellular Carcinoma Patients
    Asrinda, Indria
    Antarianto, Radiana Dhewayani
    Jusuf, Ahmad Aulia
    Ahani, Ardhi Rahman
    Jasirwan, Chyntia Olivia Maurine
    Ritchie, Ni Ken
    Aditya, Robby Nur
    Irawan, Cosphiadi
    MAKARA JOURNAL OF HEALTH RESEARCH, 2024, 28 (03):
  • [10] Natural killer cells: from bench to cancer therapy
    Boyiadzis, Michael
    Foon, Kenneth A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (10) : 967 - 970